Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Johnson

Showing results (81-90 of 163) with videos related to

Pageof 17
Sort By:
Neurochemistry International|December 12, 2001
Does tissue transglutaminase play a role in Huntington's disease?Mathieu Lesort, WanJoo Chun, Janusz Tucholski, et al.
Frontiers in Neurology|September 13, 2013
Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer diseaseAdrianne S Chesser, Susanne M Pritchard, Gail V W Johnson
International Journal of Molecular Sciences|April 13, 2023
Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory MatrixJacen Emerson, Thomas Delgado, Peter Girardi, et al.
Progress in Experimental Tumor Research|March 5, 2005
Transglutaminases in neurodegenerative disordersCraig D C Bailey, Janusz Tucholski, Gail V W Johnson
Advances in Experimental Medicine and Biology|February 26, 2020
Tau Clearance MechanismsMaoping Tang, Jarreau Harrison, Carol A Deaton, et al.
Human Molecular Genetics|February 14, 2004
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathwayQingmin Ruan, Mathieu Lesort, Marcy E MacDonald, et al.
Neuroscience Letters|July 5, 2005
Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse modelYeun Su Choo, Zhengkuan Mao, Gail V W Johnson, et al.
International Journal of Clinical and Experimental Medicine|December 17, 2008
The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 TransglutaminaseQingmin Ruan, Janusz Tucholski, Soner Gundemir, et al.
Reviews in the Neurosciences|April 15, 2015
Autophagy in Alzheimer's diseaseAmeneh Zare-Shahabadi, Eliezer Masliah, Gail V W Johnson, et al.
Molecular and Cellular Neurosciences|December 4, 2017
Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viabilityLaura Yunes-Medina, Alex Paciorkowski, Yan Nuzbrokh, et al.
Pageof 17

Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Neurochemistry International|December 12, 2001
Does tissue transglutaminase play a role in Huntington's disease?Mathieu Lesort, WanJoo Chun, Janusz Tucholski, et al.
Frontiers in Neurology|September 13, 2013
Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer diseaseAdrianne S Chesser, Susanne M Pritchard, Gail V W Johnson
International Journal of Molecular Sciences|April 13, 2023
Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory MatrixJacen Emerson, Thomas Delgado, Peter Girardi, et al.
Progress in Experimental Tumor Research|March 5, 2005
Transglutaminases in neurodegenerative disordersCraig D C Bailey, Janusz Tucholski, Gail V W Johnson
Advances in Experimental Medicine and Biology|February 26, 2020
Tau Clearance MechanismsMaoping Tang, Jarreau Harrison, Carol A Deaton, et al.
Human Molecular Genetics|February 14, 2004
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathwayQingmin Ruan, Mathieu Lesort, Marcy E MacDonald, et al.
Neuroscience Letters|July 5, 2005
Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse modelYeun Su Choo, Zhengkuan Mao, Gail V W Johnson, et al.
International Journal of Clinical and Experimental Medicine|December 17, 2008
The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 TransglutaminaseQingmin Ruan, Janusz Tucholski, Soner Gundemir, et al.
Reviews in the Neurosciences|April 15, 2015
Autophagy in Alzheimer's diseaseAmeneh Zare-Shahabadi, Eliezer Masliah, Gail V W Johnson, et al.
Molecular and Cellular Neurosciences|December 4, 2017
Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viabilityLaura Yunes-Medina, Alex Paciorkowski, Yan Nuzbrokh, et al.
Pageof 17